Tolerability and Immunogenicity Study of FLUVAL P H1N1 Monovalent Influenza Vaccine of Omninvest in Children and Adolescents.
Phase of Trial: Phase IV
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine
- Indications Influenza A virus H1N1 subtype; Influenza virus infections
- Focus Adverse reactions
- Sponsors Omninvest
- 01 Aug 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
- 01 Aug 2011 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
- 01 Aug 2011 Official Title amended as reported by ClinicalTrials.gov.